Sep 06 2024 This Week in Cardiology

Sep 06 2024 This Week in Cardiology

Feedback on ABYSS and beta-blockers, more ESC recap, including SHAM-PVI, FINEARTS-HF, and RESHAPE HF2 trials are the topics John Mandrola, MD, discusses in today's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. Feedback on ABYSS

Setbacks After Stopping Beta-Blockers

https://www.medscape.com/viewarticle/setbacks-after-stopping-beta-blockers-2024a1000fv7

Beta-Blockers Post-MI? No for Me, Even After the ABYSS Trial

https://www.medscape.com/viewarticle/beta-blockers-post-mi-no-me-even-after-abyss-trial-2024a1000fva

  • ABYSS trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204
  • REDUCE AMI https://www.nejm.org/doi/full/10.1056/NEJMoa2401479
  • QOL paper REDUCE AMI https://doi.org/10.1093/ehjcvp/pvae062
  • Atenolol ED paper 10.1016/j.ehj.2003.08.016

II. SHAM-PVI

  • JAMA SHAM-PVI paper https://jamanetwork.com/journals/jama/article-abstract/2823283
  • Gupta QOL paper https://pubmed.ncbi.nlm.nih.gov/33952593/

III. FINEARTS HF

Finerenone Benefits Heart Failure With Preserved EF

https://www.medscape.com/viewarticle/finerenone-benefits-heart-failure-preserved-ef-2024a1000fza

Topline Finerenone Results Point to Advance in Heart Failure

https://www.medscape.com/viewarticle/topline-finerenone-results-point-advance-heart-failure-2024a1000fq2

  • FINEHEARTS -HF NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2407107
  • FIDELIO-DKD https://www.nejm.org/doi/full/10.1056/NEJMoa2025845
  • FIGARO-DKD https://www.nejm.org/doi/full/10.1056/NEJMoa2110956
  • Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF? https://doi.org/10.1016/j.jacc.2024.08.033

IV. RESHAPE HF

TEER in Functional MR: Data Deluge, but No Easy Answers

https://www.medscape.com/viewarticle/teer-functional-mr-data-deluge-no-easy-answers-2024a1000fvg

  • Mitra FR https://www.nejm.org/doi/full/10.1056/NEJMoa1805374
  • COAPT https://www.nejm.org/doi/full/10.1056/NEJMoa1806640
  • RESHAPE- HF2 https://www.nejm.org/doi/full/10.1056/NEJMoa2314328
  • RESHAPE Subgroup paper https://doi.org/10.1016/j.jacc.2024.08.027

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(411)

Jun 26 2026 This Week in Cardiology

Jun 26 2026 This Week in Cardiology

Listener feedback on valvular heart disease, statins and frailty, left atrial posterior wall ablation fails again, interpreting medical tests and AI ECG reading are the topics John Mandrola, MD, discu...

26 Kesä 33min

Jun 19 2026 This Week in Cardiology

Jun 19 2026 This Week in Cardiology

Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, and a CMS proposal to expand TAVR coverage are the topics John Mandrola, MD...

19 Kesä 36min

Jun 12 2026 This Week in Cardiology

Jun 12 2026 This Week in Cardiology

Listener feedback, transcatheter tricuspid valve replacement, a new metabolic disease called CKM, the ARISE-FLUIDS Trial, the BIHCA trial, and temporal trends in ICD therapies are the topics John Mand...

12 Kesä 30min

Jun 05 2026 This Week in Cardiology

Jun 05 2026 This Week in Cardiology

Chemical cardioversion in the ED, HF monitoring, weight loss in AF, and surgical LAA excision are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcar...

5 Kesä 31min

May 29 2026 This Week in Cardiology

May 29 2026 This Week in Cardiology

A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in cardiac amyloidosis, and a lipid guideline rebuttal are the topics John Mandrola, ...

29 Touko 28min

May 22 2026 This Week in Cardiology

May 22 2026 This Week in Cardiology

Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid guidelines are the topics John Mandrola, MD, discusses in this week'...

22 Touko 32min

May 15, 2026 This Week in Cardiology

May 15, 2026 This Week in Cardiology

Another positive digoxin trial, another classic coronary physiology study from Imperial College London (ORBITA-FIRE), news in hypertrophic cardiomyopathy, and TAVR done in the wrong patients are the t...

15 Touko 31min

May 08 2026 This Week in Cardiology

May 08 2026 This Week in Cardiology

Listener feedback from the DanGer Shock investigators, complete vs staged revascularization, polygenic risk scores, and quality improvement failure in an RCT are the topics John Mandrola, MD, discusse...

8 Touko 29min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
hippokrateen-vastaanotolla
utelias-mieli
rss-hereilla
filocast-filosofian-perusteet
tiedekulma-podcast
docemilia
rss-vaasan-yliopiston-podcastit
rss-tiedetta-vai-tarinaa
rss-totuuden-liepeilla
ihanat-ipanat
radio-antro
rss-bios-podcast
rss-poliisin-mieli
rss-ammamafia
rss-kasvikutsut